臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wu s g"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-25 of 224 (9 Page(s) Totally)
1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-08-10T02:37:41Z	Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan	Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; Yu C.-J.; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2022-06-27T07:07:54Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; CHONG-JEN YU; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:54Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Wu S.-G.; Gow C.-H.; CHONG-JEN YU; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:53Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; CHONG-JEN YU; Tsai M.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:35Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Wu S.-G.; Yang C.-H.; CHONG-JEN YU; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:32Z	Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction	Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Tsai M.-F.; Lee Y.-C.; CHONG-JEN YU; Shih J.-Y.
臺大學術典藏	2022-06-27T07:07:28Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏	2022-06-27T07:07:27Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:06:27Z	Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation	Wu S.-G.; Shih J.-Y.; CHONG-JEN YU; Yang P.-C.
臺大學術典藏	2022-06-27T07:06:21Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; CHONG-JEN YU; Shin J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:02:08Z	RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer	Tsai T.-H.; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; CHONG-JEN YU; Yue S.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:02:06Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; CHONG-JEN YU; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:02:00Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; CHONG-JEN YU; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:01:58Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.; CHONG-JEN YU; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:01:50Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; CHONG-JEN YU; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2022-06-27T07:01:45Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; CHONG-JEN YU; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2022-06-27T07:01:41Z	Treatment outcome of patients with isoniazid mono-resistant tuberculosis	Chien J.-Y.; Chen Y.-T.; Wu S.-G.; Lee J.-J.; Wang J.-Y.; CHONG-JEN YU
臺大學術典藏	2022-06-27T07:01:38Z	Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion	Tsai T.-H.; Wu S.-G.; Hsieh M.-S.; CHONG-JEN YU; Yang J.C.H.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:26Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:23Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:19Z	Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma	Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:16Z	The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition	Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T07:00:08Z	Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors	Wu S.-G.; Chang Y.-L.; CHONG-JEN YU; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:59Z	Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2022-06-27T06:59:56Z	IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer	Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; CHONG-JEN YU; Shih J.-Y.

Showing items 1-25 of 224 (9 Page(s) Totally)
1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2809385
	???header.visitor??? : 26920987 ???header.onlineuser??? : 1264 ???header.sponsordeclaration???